Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer
2023
608 citations
Journal Article
green Open Access
Field-Weighted Citation Impact:
163.04
Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer | Researchclopedia
Thomas Winder
·
The University of Texas MD Anderson Cancer Center
Р. А. Зуков
·
The University of Texas MD Anderson Cancer Center
Gabriel Garbaos
·
The University of Texas MD Anderson Cancer Center
Shugeng Gao
·
The University of Texas MD Anderson Cancer Center
Hiroaki Kuroda
·
The University of Texas MD Anderson Cancer Center
Gyula Ostoros
·
The University of Texas MD Anderson Cancer Center
Tho V. Tran
·
The University of Texas MD Anderson Cancer Center
Jian You
·
The University of Texas MD Anderson Cancer Center
Kang‐Yun Lee
·
The University of Texas MD Anderson Cancer Center
Lorenzo Antonuzzo
·
The University of Texas MD Anderson Cancer Center
Zsolt Pápai-Székely
·
The University of Texas MD Anderson Cancer Center
Hiroaki Akamatsu
·
The University of Texas MD Anderson Cancer Center
Bivas Biswas
·
The University of Texas MD Anderson Cancer Center
Alexander I. Spira
·
The University of Texas MD Anderson Cancer Center
Jeffrey Crawford
·
The University of Texas MD Anderson Cancer Center
Ha Le
·
The University of Texas MD Anderson Cancer Center
Mike Aperghis
·
AstraZeneca (United Kingdom)
Gary J. Doherty
·
AstraZeneca (United Kingdom)
Helen Mann
·
AstraZeneca (United Kingdom)
Tamer M. Fouad
·
The University of Texas MD Anderson Cancer Center
Martin Reck
·
The University of Texas MD Anderson Cancer Center